However, our results suggested that inhibiting TBK1, whether using siRNA or AMX, could not improve hyperglycemia or obesity in db/db mice, a type of mutant mouse of the Lepr gene. The gene discussed is LEPR; the disease is obesity due to melanocortin 4 receptor deficiency.